166 related articles for article (PubMed ID: 29713204)
1. Efficacy and patient satisfaction after NovaSure and Minerva endometrial ablation for treating abnormal uterine bleeding: a retrospective comparative study.
Scordalakes C; delRosario R; Shimer A; Stankiewicz R
Int J Womens Health; 2018; 10():137-145. PubMed ID: 29713204
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Combined Bipolar Radiofrequency Impedance-Controlled Endometrial Ablation with Levonorgestrel Intrauterine System versus Bipolar Radiofrequency Endometrial Ablation Alone in Women with Abnormal Uterine Bleeding.
Zhao H; Yang B; Feng L; Li H; Shang H; Zhao Z; Dai Y
J Minim Invasive Gynecol; 2020; 27(3):774-780. PubMed ID: 31201942
[TBL] [Abstract][Full Text] [Related]
3. A double-blind randomized trial comparing the Cavaterm and the NovaSure endometrial ablation systems for the treatment of dysfunctional uterine bleeding.
Abbott J; Hawe J; Hunter D; Garry R
Fertil Steril; 2003 Jul; 80(1):203-8. PubMed ID: 12849825
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the NovaSure endometrial ablation procedure in women with uterine cavity length over 10 cm.
Thiel JA; Briggs MM; Pohlman S; Rattray D
J Obstet Gynaecol Can; 2014 Jun; 36(6):491-497. PubMed ID: 24927186
[TBL] [Abstract][Full Text] [Related]
5. Ten-year literature review of global endometrial ablation with the NovaSure® device.
Gimpelson RJ
Int J Womens Health; 2014; 6():269-80. PubMed ID: 24648771
[TBL] [Abstract][Full Text] [Related]
6. Cost effectiveness of endometrial ablation with the NovaSure(®) system versus other global ablation modalities and hysterectomy for treatment of abnormal uterine bleeding: US commercial and Medicaid payer perspectives.
Miller JD; Lenhart GM; Bonafede MM; Basinski CM; Lukes AS; Troeger KA
Int J Womens Health; 2015; 7():59-73. PubMed ID: 25610002
[TBL] [Abstract][Full Text] [Related]
7. One-Year Follow-Up Results of a Multicenter, Single-Arm, Objective Performance Criteria-Controlled International Clinical Study of the Safety and Efficacy of the Minerva Endometrial Ablation System.
Laberge P; Garza-Leal J; Fortin C; Sabbah R; Fulop T; Pásztor N; Bacsko G
J Minim Invasive Gynecol; 2015; 22(7):1169-77. PubMed ID: 26072204
[TBL] [Abstract][Full Text] [Related]
8. A Randomized Controlled Multicenter US Food and Drug Administration Trial of the Safety and Efficacy of the Minerva Endometrial Ablation System: One-Year Follow-Up Results.
Laberge P; Garza-Leal J; Fortin C; Grainger D; Johns DA; Adkins RT; Presthus J; Basinski C; Swarup M; Gimpelson R; Leyland N; Thiel J; Harris M; Burnett PE; Ray GF
J Minim Invasive Gynecol; 2017 Jan; 24(1):124-132. PubMed ID: 27687851
[TBL] [Abstract][Full Text] [Related]
9. Women's satisfaction and symptoms following NovaSure endometrial ablation: a postal questionnaire survey in Lothian, Scotland.
Unger HW; Megaly E; Dick A; Horne AW; Milne S; West C
J Obstet Gynaecol; 2014 May; 34(4):350-1. PubMed ID: 24484297
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of endometrial ablation for treating abnormal uterine bleeding in pre- and postmenopausal women with liver cirrhosis.
Liu Q; Li XL; Liu JJ; Song XH; Jiang XY; Li W; Zhang H; Pan CQ
J Obstet Gynaecol Res; 2016 Dec; 42(12):1753-1760. PubMed ID: 27647778
[TBL] [Abstract][Full Text] [Related]
11. Use of the NovaSure Impedance Controlled Endometrial Ablation System in patients with intracavitary disease: 12-month follow-up results of a prospective, single-arm clinical study.
Sabbah R; Desaulniers G
J Minim Invasive Gynecol; 2006; 13(5):467-71. PubMed ID: 16962534
[TBL] [Abstract][Full Text] [Related]
12. Endometrial ablation or resection versus levonorgestrel intra-uterine system for the treatment of women with heavy menstrual bleeding and a normal uterine cavity: a systematic review with meta-analysis.
Bergeron C; Laberge PY; Boutin A; Thériault MA; Valcourt F; Lemyre M; Maheux-Lacroix S
Hum Reprod Update; 2020 Feb; 26(2):302-311. PubMed ID: 31990359
[TBL] [Abstract][Full Text] [Related]
13. Novasure as a mechanical endometrial preparation agent in large uteri.
Potti S; Uppal S; Chatwani AJ; Hernandez E; Dandolu V
JSLS; 2012; 16(4):537-41. PubMed ID: 23484560
[TBL] [Abstract][Full Text] [Related]
14. NovaSure bipolar radiofrequency endometrial ablation: report of 200 cases.
Baskett TF; Clough H; Scott TA
J Obstet Gynaecol Can; 2005 May; 27(5):473-6. PubMed ID: 16100642
[TBL] [Abstract][Full Text] [Related]
15. Novasure impedance control system versus microwave endometrial ablation for the treatment of dysfunctional uterine bleeding: a double-blind, randomized controlled trial.
Athanatos D; Pados G; Venetis CA; Stamatopoulos P; Rousso D; Tsolakidis D; Stamatopoulos CP; Tarlatzis BC
Clin Exp Obstet Gynecol; 2015; 42(3):347-51. PubMed ID: 26152008
[TBL] [Abstract][Full Text] [Related]
16. Levonorgestrel-releasing intrauterine system versus endometrial ablation for heavy menstrual bleeding.
Beelen P; van den Brink MJ; Herman MC; Geomini PMAJ; Dekker JH; Duijnhoven RG; Mak N; van Meurs HS; Coppus SF; van der Steeg JW; Eising HP; Massop-Helmink DS; Klinkert ER; Nieboer TE; Timmermans A; van der Voet LF; Veersema S; Smeets NAC; Schutte JM; van Baal M; Bossuyt PM; Mol BWJ; Berger MY; Bongers MY
Am J Obstet Gynecol; 2021 Feb; 224(2):187.e1-187.e10. PubMed ID: 32795428
[TBL] [Abstract][Full Text] [Related]
17. Clinical analysis of 2152 cases of abnormal uterine bleeding treated by NovaSure endometrial ablation.
Xie H; Wan Y; Yi S; Zeng F; Sun X; Yang Y; Xiao S
Int J Gynaecol Obstet; 2022 Aug; 158(2):301-307. PubMed ID: 34653258
[TBL] [Abstract][Full Text] [Related]
18. Abnormal Uterine Bleeding Control by Sequential Application of Hysteroscopic Lesion Morcellation and Endometrial Ablation.
Rubino RJ; Roy KH; Presthus J; Trupin S
J Reprod Med; 2017; 62(3-4):102-10. PubMed ID: 30230300
[TBL] [Abstract][Full Text] [Related]
19. Improved premenstrual syndrome symptoms after NovaSure endometrial ablation.
Lukes AS; McBride RJ; Herring AH; Fried M; Sherwani A; Dell D
J Minim Invasive Gynecol; 2011; 18(5):607-11. PubMed ID: 21872168
[TBL] [Abstract][Full Text] [Related]
20. A randomized, multicenter trial of safety and efficacy of the NovaSure system in the treatment of menorrhagia.
Cooper J; Gimpelson R; Laberge P; Galen D; Garza-Leal JG; Scott J; Leyland N; Martyn P; Liu J
J Am Assoc Gynecol Laparosc; 2002 Nov; 9(4):418-28. PubMed ID: 12386350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
